<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7076579/results/search/funders/results.xml">
  <result pre="the type and duration of the immunosuppressive treatment used. The" exact="American Gastroenterological Association" post="(AGA) classified HBVr risk as low (&amp;lt;1%), moderate (1–10%),"/>
  <result pre="the serological screening markers (HBsAg, anti-HBc) as suggested by recent" exact="American Association for the Study of Liver Diseases" post="(AASLD) and European Association for the Study of the"/>
  <result pre="two-dose HBV vaccine was recently approved by the United States" exact="Food and Drug Administration" post="(FDA) and is already recommended by Advisory Committee on"/>
  <result pre="386: 1546–1555.26231459 2collab: World Health Organisation. Global hepatitis report, 2017Geneva:" exact="World Health Organization," post="2017. 3DougadosMSoubrierMAntunezA, et al.Prevalence of comorbidities in rheumatoid arthritis"/>
  <result pre="insufficiency. Endocrinol Diabetes Metab2019; e00071.31294085 33Di BisceglieAMLokASMartinP, et al.Recent US" exact="Food and Drug Administration" post="warnings on hepatitis B reactivation with immune-suppressing and anticancer"/>
 </snippets>
</snippetsTree>
